Enhanced Placental Stem Cells and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/US2014/025202, filed Mar 13, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,329,529 | Enhanced Placental Stem Cells and Uses Thereof In force · High confidence | Celeniv Pte. Ltd. | In force | High confidence | ||
| US 11,512,282 | Enhanced Placental Stem Cells and Uses Thereof In force · High confidence | Celeniv Pte. Ltd. | In force | High confidence | ||
| Application 18/048,291 | Enhanced Placental Stem Cells and Uses Thereof Abandoned Abandoned Jul 9, 2026 | Celeniv Pte. Ltd. | Abandoned | Abandoned Jul 9, 2026 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Celeniv Pte. Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.